Wedbush Cuts Earnings Estimates for Apogee Therapeutics
Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) – Investment analysts at Wedbush reduced their Q1 2025 earnings estimates for Apogee Therapeutics in a note issued to investors on Monday, March 3rd. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings of ($1.24) per share for the quarter, down from their prior forecast […]
Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) – Investment analysts at Wedbush reduced their Q1 2025 earnings estimates for Apogee Therapeutics in a note issued to investors on Monday, March 3rd. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings of ($1.24) per share for the quarter, down from their prior forecast […]
